EUROPE BIOCHIPS MARKET 2019-2027


MARKET OUTLOOK

The biochips market in Europe is projected to develop at a CAGR of 18.91% during the forecasted years of 2019-2027. The growing application of biochips in the areas of biotechnology along with increased government funding in the development and promotion of biotechnology sector is fostering the growth of the biochips market in the European region.

The biochips market is segmented into three major divisions such as end-users, type, and substrate materials. Countries such as the United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe are studied in the Europe biochips market. The lack of awareness related to biochips, the unsettled regulatory guidelines and the availability of low-cost alternative technologies is majorly hindering the growth of the biochips market in the region. Nevertheless, factors such as growing innovation in the biochips market, evolving funds for R&D, and various initiatives adopted by the government to develop and promote biochips are the some of the reasons expected to propel the growth of the Europe biochips market in the coming years. 

COMPETITIVE OUTLOOK 

The top players in the Europe biochips market are Perkinelmer Inc., Biomerieux Sa., Fluidigm Corporation, Merck Gmbh, Cepheid Inc., Illumina Inc., Gamida For Life Group., Origene Technologies Inc., Imgenex, Thermo Fisher Scientific Inc., Agilent Technology Inc., Biochain Institute Inc., Samsung Electronics Inc., Cybrdi Inc., and Bio-Rad Laboratories Inc.
TABLE OF CONTENT
1. BIOCHIPS MARKET - SUMMARY 
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.3. EVOLUTION & TRANSITION OF BIOCHIPS 
2.4. PORTER'S FIVE FORCE ANALYSIS
2.5. MARKET ATTRACTIVENESS MATRIX 
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.8. VENDOR SCORECARD
2.9. KEY IMPACT ANALYSIS 
2.10. MARKET OPPORTUNITY INSIGHTS
2.11. INDUSTRY PLAYER POSITIONING
2.12. KEY MARKET STRATEGIES 
2.13. MARKET DRIVERS
2.13.1. GROWTH IN PERSONALIZED MEDICINES
2.13.2. RISING INCIDENCES & TREATMENT OF CANCER 
2.13.3. CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE
2.13.4. INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D
2.14. MARKET RESTRAINTS
2.14.1. INEQUALITY IN HEALTHCARE ACCESS
2.14.2. INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS
2.14.3. COMPLEXITY OF BIOLOGICAL SYSTEMS
2.15. MARKET OPPORTUNITIES
2.15.1. DEVELOPMENTS IN BIOCHIPS TECHNOLOGY
2.15.2. WIDENING APPLICATION AREAS OF BIOCHIPS 
2.16. MARKET CHALLENGES
2.16.1. AVAILABILITY OF SUBSTITUTE TECHNOLOGIES
2.16.2. UNCLEAR REGULATORY GUIDELINES
2.16.3. COST CONSTRAINTS
3. BIOCHIPS INDUSTRY OUTLOOK – BY TYPE
3.1. DNA CHIPS
3.1.1. AGRICULTURAL BIOTECHNOLOGY
3.1.2. CANCER DIAGNOSTICS & TREATMENT
3.1.3. DRUG DISCOVERY
3.1.4. GENE EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER DNA CHIPS
3.2. LAB ON A CHIP
3.2.1. CLINICAL DIAGNOSTICS
3.2.2. DRUG DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER LAB ON A CHIP
3.3. PROTEIN CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG DISCOVERY
3.3.3. EXPRESSION PROFILING
3.3.4. HIGH THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER PROTEIN CHIPS
3.4. OTHER CHIPS
3.4.1. CELL ARRAYS
3.4.2. TISSUE ARRAYS
4. BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER SUBSTRATE MATERIALS
5. BIOCHIPS INDUSTRY OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS AND DIAGNOSTICS CENTERS
5.3. ACADEMIC AND RESEARCH INSTITUTE
6. BIOCHIPS INDUSTRY - EUROPE 
6.1. UNITED KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. ITALY
6.5. SPAIN
6.6. RUSSIA
6.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGY INC.
7.2. BIOCHAIN INSTITUTE INC.
7.3. BIOMERIEUX SA
7.4. BIO-RAD LABORATORIES INC.
7.5. CEPHEID INC.
7.6. CYBRDI INC.
7.7. FLUIDIGM CORPORATION
7.8. GAMIDA FOR LIFE GROUP
7.9. ILLUMINA INC.
7.10. IMGENEX
7.11. MERCK GMBH
7.12. ORIGENE TECHNOLOGIES INC.
7.13. PERKINELMER INC.
7.14. SAMSUNG ELECTRONICS INC.
7.15. THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE 
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY



TABLE LIST  
TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET 
TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET 
TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 
TABLE 6. EUROPE BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 7. EUROPE BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) 
TABLE 8. EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION) 
TABLE 9. EUROPE BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION) 

FIGURE LIST
FIGURE 1. EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT ANALYSIS
FIGURE 4. TIMELINE OF BIOCHIPS
FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 
FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET 
FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)
FIGURE 9. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE 
FIGURE 10. EUROPE BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) 
FIGURE 11. EUROPE DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 12. EUROPE DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
FIGURE 13. EUROPE DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) 
FIGURE 14. EUROPE DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) 
FIGURE 15. EUROPE DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) 
FIGURE 16. EUROPE DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) 
FIGURE 17. EUROPE DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) 
FIGURE 18. EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION) 
FIGURE 19. EUROPE LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 20. EUROPE LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 21. EUROPE LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 22. EUROPE LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION) 
FIGURE 23. EUROPE LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) 
FIGURE 24. EUROPE LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 25. EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 26. EUROPE PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 27. EUROPE PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 28. EUROPE PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 29. EUROPE PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
FIGURE 30. EUROPE PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 31. EUROPE PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 32. EUROPE BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 33. EUROPE OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 34. EUROPE OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. EUROPE BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) 
FIGURE 36. EUROPE BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 37. EUROPE BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 38. EUROPE BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
FIGURE 39. EUROPE BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
FIGURE 40. EUROPE BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)
FIGURE 41. EUROPE BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
FIGURE 42. EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)  
FIGURE 43. UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 44. GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 45. FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 46. ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 47. SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 48. RUSSIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 49. REST OF EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

TABLE LIST TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET TABLE 5. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 TABLE 6. EUROPE BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION) TABLE 7. EUROPE BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) TABLE 8. EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION) TABLE 9. EUROPE BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION) FIGURE LIST FIGURE 1. EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET FIGURE 3. KEY IMPACT ANALYSIS FIGURE 4. TIMELINE OF BIOCHIPS FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018 FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%) FIGURE 9. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE FIGURE 10. EUROPE BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) FIGURE 11. EUROPE DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION) FIGURE 12. EUROPE DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION) FIGURE 13. EUROPE DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 14. EUROPE DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) FIGURE 15. EUROPE DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 16. EUROPE DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) FIGURE 17. EUROPE DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 18. EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 19. EUROPE LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 20. EUROPE LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 21. EUROPE LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 22. EUROPE LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION) FIGURE 23. EUROPE LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 24. EUROPE LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 25. EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 26. EUROPE PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 27. EUROPE PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 28. EUROPE PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION) FIGURE 29. EUROPE PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION) FIGURE 30. EUROPE PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 31. EUROPE PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 32. EUROPE BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 33. EUROPE OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 34. EUROPE OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 35. EUROPE BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) FIGURE 36. EUROPE BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS) FIGURE 37. EUROPE BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS) FIGURE 38. EUROPE BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS) FIGURE 39. EUROPE BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS) FIGURE 40. EUROPE BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS) FIGURE 41. EUROPE BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS) FIGURE 42. EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %) FIGURE 43. UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 44. GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 45. FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 46. ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 47. SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 48. RUSSIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 49. REST OF EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Biotechnology Reports

North America Creatinine Measurement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Kits, Reagents); Type (Enzymatic Method, Jaffe's Kinetic Method); Sample Type (Blood or Serum, Urine); End-User (Hospitals, Diagnostic Laboratories, Others), and Country

The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027. The growth of the creatinine measurement market is a...

Europe Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Europe, the Biodefense Market, is anticipated to reach US$ 2,516.91 Mn in 2027 from US$ 1,286.58 Mn in 2019. The market is projected to grow with a CAGR of 8.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of favorab...

Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Asia Pacific, the Biodefense Market, is anticipated to reach US$ 1,520.67 Mn in 2027 from US$ 723.70 Mn in 2019. The market is projected to grow with a CAGR of 9.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of fav...

North America Biodefense Market to 2027 - Regional Analysis and Forecasts by North America Biodefense Market to 2027 - Regional Analysis and Forecasts by Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others); and Country

The North American biodefense market is estimated to reach US$ 3,357.83 Mn by 2027 from US$ 1,569.29 Mn in 2019; it is projected to grow at a CAGR of 10.1% from 2019 to 2027. The growth of the biodefense market is primarily ascribed to the presence o...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research